Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

Clicks: 144
ID: 116579
2007
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #299 of 438 articles by views in acta neuropathologica

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 438 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The aim of this study was to improve the neuropathologic recognition and provide criteria for the pathological diagnosis in the neurodegenerative diseases grouped as frontotemporal lobar degeneration (FTLD); revised criteria are proposed. Recent advances in molecular genetics, biochemistry, and neuropathology of FTLD prompted the Midwest Consortium for Frontotemporal Lobar Degeneration and experts at other centers to review and revise the existing neuropathologic diagnostic criteria for FTLD. The proposed criteria for FTLD are based on existing criteria, which include the tauopathies [FTLD with Pick bodies, corticobasal degeneration, progressive supranuclear palsy, sporadic multiple system tauopathy with dementia, argyrophilic grain disease, neurofibrillary tangle dementia, and FTD with microtubule-associated tau (MAPT) gene mutation, also called FTD with parkinsonism linked to chromosome 17 (FTDP-17)]. The proposed criteria take into account new disease entities and include the novel molecular pathology, TDP-43 proteinopathy, now recognized to be the most frequent histological finding in FTLD. TDP-43 is a major component of the pathologic inclusions of most sporadic and familial cases of FTLD with ubiquitin-positive, tau-negative inclusions (FTLD-U) with or without motor neuron disease (MND). Molecular genetic studies of familial cases of FTLD-U have shown that mutations in the progranulin (PGRN) gene are a major genetic cause of FTLD-U. Mutations in valosin-containing protein (VCP) gene are present in rare familial forms of FTD, and some families with FTD and/or MND have been linked to chromosome 9p, and both are types of FTLD-U. Thus, familial TDP-43 proteinopathy is associated with defects in multiple genes, and molecular genetics is required in these cases to correctly identify the causative gene defect. In addition to genetic heterogeneity amongst the TDP-43 proteinopathies, there is also neuropathologic heterogeneity and there is a close relationship between genotype and FTLD-U subtype. In addition to these recent significant advances in the neuropathology of FTLD-U, novel FTLD entities have been further characterized, including neuronal intermediate filament inclusion disease. The proposed criteria incorporate up-to-date neuropathology of FTLD in the light of recent immunohistochemical, biochemical, and genetic advances. These criteria will be of value to the practicing neuropathologist and provide a foundation for clinical, clinico-pathologic, mechanistic studies and in vivo models of pathogenesis of FTLD.
Reference Key
cairns2007actaneuropathologic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Nigel J. Cairns;Eileen H. Bigio;Ian R. A. Mackenzie;Manuela Neumann;Virginia M.-Y. Lee;Kimmo J. Hatanpaa;Charles L. White;Julie A. Schneider;Lea Tenenholz Grinberg;Glenda Halliday;Charles Duyckaerts;James S. Lowe;Ida E. Holm;Markus Tolnay;Koichi Okamoto;Hideaki Yokoo;Shigeo Murayama;John Woulfe;David G. Munoz;Dennis W. Dickson;Paul G. Ince;John Q. Trojanowski;David M. A. Mann;Nigel J. Cairns;Eileen H. Bigio;Ian R. A. Mackenzie;Manuela Neumann;Virginia M.-Y. Lee;Kimmo J. Hatanpaa;Charles L. White;Julie A. Schneider;Lea Tenenholz Grinberg;Glenda Halliday;Charles Duyckaerts;James S. Lowe;Ida E. Holm;Markus Tolnay;Koichi Okamoto;Hideaki Yokoo;Shigeo Murayama;John Woulfe;David G. Munoz;Dennis W. Dickson;Paul G. Ince;John Q. Trojanowski;David M. A. Mann;
Journal acta neuropathologica
Year 2007
DOI
doi:10.1007/s00401-007-0237-2
URL
https://link.springer.com/article/10.1007/s00401-007-0237-2
Keywords
pathology neurosciences

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.